Tuvia Gilat
Direttore Tecnico/Scientifico/R&S presso Galmed Medical Research Ltd.
Profilo
Tuvia Gilat is the founder of Galmed Pharmaceuticals Ltd.
which was founded in 2000.
Currently, he is the Scientific Director at Galmed Medical Research Ltd.
Dr. Gilat's former positions include Director at BioCancell Therapeutics, Inc. and Director at Tel-Aviv Sourasky Medical Center where he served as Director from 1965 to 1996.
Dr. Gilat holds a doctorate degree from The Hebrew University of Jerusalem.
Posizioni attive di Tuvia Gilat
| Società | Posizione | Inizio |
|---|---|---|
| Galmed Medical Research Ltd. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Tuvia Gilat
| Società | Posizione | Fine |
|---|---|---|
Tel-Aviv Sourasky Medical Center
 Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Tel-Aviv Sourasky Medical Center operates as a medical center. Tel Aviv Sourasky Medical Center provides progressive full-service healthcare treatment and research institutions in Israel. The Medical Center draws patients from throughout the world for specialty care and routine procedures through the medical tourism program, designed specifically for the needs of international patients. The center was founded in 1963 and is headquartered in Tel Aviv, Israel. | Direttore/Membro del Consiglio | 01/01/1996 |
| GALMED PHARMACEUTICALS LTD. | Fondatore | - |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Direttore/Membro del Consiglio | - |
Formazione di Tuvia Gilat
| The Hebrew University of Jerusalem | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GALMED PHARMACEUTICALS LTD. | Health Technology |
| Aziende private | 3 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Tel-Aviv Sourasky Medical Center operates as a medical center. Tel Aviv Sourasky Medical Center provides progressive full-service healthcare treatment and research institutions in Israel. The Medical Center draws patients from throughout the world for specialty care and routine procedures through the medical tourism program, designed specifically for the needs of international patients. The center was founded in 1963 and is headquartered in Tel Aviv, Israel. | Health Services |
| Galmed Medical Research Ltd. |
- Borsa valori
- Insiders
- Tuvia Gilat
